- '...and C is for Clioquinol' - the AbetaCs of Alzheimer's disease.
'...and C is for Clioquinol' - the AbetaCs of Alzheimer's disease.
Trends in neurosciences (2002-02-20)
Simon Melov
PMID11852134
RESUMO
Alzheimer's disease (AD) is a devastating age-related neurodegenerative disorder that has been intensively studied over the last several years. In vitro and in vivo studies have led to an understanding of some of the physico-chemical properties of amyloid, a well-characterized hallmark of AD. Clioquinol is a drug that acts on amyloid by perturbing amyloid's metallo-chemistry, and Clioquinol treatment has been shown to be beneficial in a mouse model of AD. This short review examines the recent studies relating to Clioquinol and AD, and anticipates the imminent results of a Phase II trial of Clioquinol in AD, due in March 2002.
MATERIAIS
Número do produto
Marca
Descrição do produto
SKU
Tamanho da embalagem
Disponibilidade
Preço
Quantidade
SKU
Tamanho da embalagem
Disponibilidade
Preço
Quantidade
Clioquinol, European Pharmacopoeia (EP) Reference Standard
SKU
Tamanho da embalagem
Disponibilidade
Preço
Quantidade